November 8, 2018, 4:00 pm - 6:00 pm
Cambia Grove, host Lee Huntsman, and series partner UW BioEngage are pleased to welcome Hans Bishop, former CEO of Juno Therapeutics. Hans will share his experience growing Juno from a spinoff out of the Fred Hutchinson Cancer Research Center, to a major biotech company employing more than 500 people before being acquired by Celgene for $9 billion.
The conversation will touch upon the disruptive trends Hans sees in the health care system, his advice on growing a startup, and reflections on how the current health care system is built for technologies of the past.